Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss market.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Shares of stocks with significant private credit market exposure were diving on fears about exposure to the industries being disrupted by artificial intelligence, including software.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
I’m a dividend investor, focusing on buying good businesses with historically high yields. I’ve increased my positions in Brookfield Renewable Partners, Hormel, and Clorox.
Rocket Lab is ramping up its rocket launches as it gains more customers. Intuitive Machines is working on plenty of lunar and near-space projects for NASA.
SDVKY, WDC and TCBI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 3, 2026.
UCB, CX, TCBI, LC and KC have been added to the Zacks Rank #1 (Strong Buy) List on February 3, 2026.
The tech sector is hot, but the next decade may be about power. Oklo and NuScale are designing small nuclear reactors.
Among Robinhood’s 10 most popular stocks, Wall Street analysts forecast the largest gains in Palantir and Microsoft. Palantir achieved a Rule of 40 score of 114% in the third quarter, unprecedented for a software company, but the stock is outrageously expensive.
